HEADER HYDROLASE/HYDROLASE INHIBITOR 31-MAR-21 7MAR TITLE DRUG RESISTANT HIV-1 PROTEASE (L10F, M46I, I47V, I50V, F53L, L63P, TITLE 2 I72V, G73S, V82I, I85V) IN COMPLEX WITH DRV COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASE; COMPND 3 CHAIN: D, A, B, C; COMPND 4 FRAGMENT: UNP RESIDUES 501-599; COMPND 5 SYNONYM: PR,RETROPEPSIN; COMPND 6 EC: 3.4.23.16; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 GROUP M SOURCE 3 SUBTYPE B; SOURCE 4 ORGANISM_COMMON: HIV-1; SOURCE 5 ORGANISM_TAXID: 11686; SOURCE 6 STRAIN: ISOLATE BRU/LAI; SOURCE 7 GENE: GAG-POL; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS DRUG RESISTANCE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.J.LOCKBAUM,C.A.SCHIFFER REVDAT 2 18-OCT-23 7MAR 1 REMARK REVDAT 1 09-NOV-22 7MAR 0 JRNL AUTH G.J.LOCKBAUM,C.A.SCHIFFER JRNL TITL DRUG RESISTANT HIV-1 PROTEASE (L10F, M46I, I47V, I50V, F53L, JRNL TITL 2 L63P, I72V, G73S, V82I, I85V) IN COMPLEX WITH DRV JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.1_4122 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.03 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 45256 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.870 REMARK 3 FREE R VALUE TEST SET COUNT : 1750 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.0300 - 4.0000 0.98 3495 141 0.1772 0.1852 REMARK 3 2 4.0000 - 3.1700 0.99 3449 138 0.1652 0.2037 REMARK 3 3 3.1700 - 2.7700 0.99 3428 138 0.1793 0.2194 REMARK 3 4 2.7700 - 2.5200 1.00 3432 139 0.1857 0.2800 REMARK 3 5 2.5200 - 2.3400 1.00 3408 137 0.1837 0.2145 REMARK 3 6 2.3400 - 2.2000 0.97 3304 133 0.2096 0.2745 REMARK 3 7 2.2000 - 2.0900 0.97 3346 134 0.2643 0.3145 REMARK 3 8 2.0900 - 2.0000 0.96 3275 132 0.2993 0.3471 REMARK 3 9 2.0000 - 1.9200 0.96 3247 130 0.3246 0.3966 REMARK 3 10 1.9200 - 1.8600 0.96 3328 133 0.3200 0.3773 REMARK 3 11 1.8600 - 1.8000 0.98 3304 132 0.3451 0.4068 REMARK 3 12 1.8000 - 1.7500 0.96 3277 133 0.4080 0.4064 REMARK 3 13 1.7500 - 1.7000 0.95 3213 130 0.4391 0.4680 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.320 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.310 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.71 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.018 3094 REMARK 3 ANGLE : 1.469 4228 REMARK 3 CHIRALITY : 0.084 514 REMARK 3 PLANARITY : 0.013 526 REMARK 3 DIHEDRAL : 12.450 430 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7MAR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-MAR-21. REMARK 100 THE DEPOSITION ID IS D_1000255798. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-MAR-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.07812 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48951 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650 REMARK 200 RESOLUTION RANGE LOW (A) : 46.030 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 200 DATA REDUNDANCY : 1.900 REMARK 200 R MERGE (I) : 0.06100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.71 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.9 REMARK 200 DATA REDUNDANCY IN SHELL : 1.70 REMARK 200 R MERGE FOR SHELL (I) : 1.11400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6DGX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 3.3-3.5 M NACL, 0.1 M TRIS-HCL PH 8.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 18.17000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4810 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9130 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4770 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS D 7 CG CD CE NZ REMARK 470 ARG D 41 CG CD NE CZ NH1 NH2 REMARK 470 GLU D 65 CG CD OE1 OE2 REMARK 470 LYS A 7 CG CD CE NZ REMARK 470 ARG A 41 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 43 CG CD CE NZ REMARK 470 LYS A 45 CG CD CE NZ REMARK 470 GLU B 21 CG CD OE1 OE2 REMARK 470 ARG B 41 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 43 CG CD CE NZ REMARK 470 LYS B 45 CG CD CE NZ REMARK 470 LYS C 7 CG CD CE NZ REMARK 470 GLU C 21 CG CD OE1 OE2 REMARK 470 ARG C 41 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 43 CG CD CE NZ REMARK 470 LYS C 45 CG CD CE NZ REMARK 470 GLU C 65 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HZ3 LYS B 7 O HOH B 101 1.53 REMARK 500 HZ2 LYS B 14 O HOH B 102 1.59 REMARK 500 O HOH C 219 O HOH C 277 2.04 REMARK 500 O HOH C 278 O HOH C 292 2.05 REMARK 500 NZ LYS B 7 O HOH B 101 2.06 REMARK 500 O HOH A 201 O HOH A 265 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TYR A 59 CG TYR A 59 CD2 0.079 REMARK 500 TYR C 59 CE1 TYR C 59 CZ -0.080 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 017 A 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 017 C 101 DBREF 7MAR D 1 99 UNP P03367 POL_HV1BR 501 599 DBREF 7MAR A 1 99 UNP P03367 POL_HV1BR 501 599 DBREF 7MAR B 1 99 UNP P03367 POL_HV1BR 501 599 DBREF 7MAR C 1 99 UNP P03367 POL_HV1BR 501 599 SEQADV 7MAR LYS D 7 UNP P03367 GLN 507 CONFLICT SEQADV 7MAR PHE D 10 UNP P03367 LEU 510 ENGINEERED MUTATION SEQADV 7MAR ASN D 37 UNP P03367 SER 537 CONFLICT SEQADV 7MAR ILE D 46 UNP P03367 MET 546 ENGINEERED MUTATION SEQADV 7MAR VAL D 47 UNP P03367 ILE 547 ENGINEERED MUTATION SEQADV 7MAR VAL D 50 UNP P03367 ILE 550 ENGINEERED MUTATION SEQADV 7MAR LEU D 53 UNP P03367 PHE 553 ENGINEERED MUTATION SEQADV 7MAR PRO D 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 7MAR VAL D 72 UNP P03367 ILE 572 ENGINEERED MUTATION SEQADV 7MAR SER D 73 UNP P03367 GLY 573 ENGINEERED MUTATION SEQADV 7MAR ILE D 82 UNP P03367 VAL 582 ENGINEERED MUTATION SEQADV 7MAR VAL D 85 UNP P03367 ILE 585 ENGINEERED MUTATION SEQADV 7MAR LYS A 7 UNP P03367 GLN 507 CONFLICT SEQADV 7MAR PHE A 10 UNP P03367 LEU 510 ENGINEERED MUTATION SEQADV 7MAR ASN A 37 UNP P03367 SER 537 CONFLICT SEQADV 7MAR ILE A 46 UNP P03367 MET 546 ENGINEERED MUTATION SEQADV 7MAR VAL A 47 UNP P03367 ILE 547 ENGINEERED MUTATION SEQADV 7MAR VAL A 50 UNP P03367 ILE 550 ENGINEERED MUTATION SEQADV 7MAR LEU A 53 UNP P03367 PHE 553 ENGINEERED MUTATION SEQADV 7MAR PRO A 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 7MAR VAL A 72 UNP P03367 ILE 572 ENGINEERED MUTATION SEQADV 7MAR SER A 73 UNP P03367 GLY 573 ENGINEERED MUTATION SEQADV 7MAR ILE A 82 UNP P03367 VAL 582 ENGINEERED MUTATION SEQADV 7MAR VAL A 85 UNP P03367 ILE 585 ENGINEERED MUTATION SEQADV 7MAR LYS B 7 UNP P03367 GLN 507 CONFLICT SEQADV 7MAR PHE B 10 UNP P03367 LEU 510 ENGINEERED MUTATION SEQADV 7MAR ASN B 37 UNP P03367 SER 537 CONFLICT SEQADV 7MAR ILE B 46 UNP P03367 MET 546 ENGINEERED MUTATION SEQADV 7MAR VAL B 47 UNP P03367 ILE 547 ENGINEERED MUTATION SEQADV 7MAR VAL B 50 UNP P03367 ILE 550 ENGINEERED MUTATION SEQADV 7MAR LEU B 53 UNP P03367 PHE 553 ENGINEERED MUTATION SEQADV 7MAR PRO B 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 7MAR VAL B 72 UNP P03367 ILE 572 ENGINEERED MUTATION SEQADV 7MAR SER B 73 UNP P03367 GLY 573 ENGINEERED MUTATION SEQADV 7MAR ILE B 82 UNP P03367 VAL 582 ENGINEERED MUTATION SEQADV 7MAR VAL B 85 UNP P03367 ILE 585 ENGINEERED MUTATION SEQADV 7MAR LYS C 7 UNP P03367 GLN 507 CONFLICT SEQADV 7MAR PHE C 10 UNP P03367 LEU 510 ENGINEERED MUTATION SEQADV 7MAR ASN C 37 UNP P03367 SER 537 CONFLICT SEQADV 7MAR ILE C 46 UNP P03367 MET 546 ENGINEERED MUTATION SEQADV 7MAR VAL C 47 UNP P03367 ILE 547 ENGINEERED MUTATION SEQADV 7MAR VAL C 50 UNP P03367 ILE 550 ENGINEERED MUTATION SEQADV 7MAR LEU C 53 UNP P03367 PHE 553 ENGINEERED MUTATION SEQADV 7MAR PRO C 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 7MAR VAL C 72 UNP P03367 ILE 572 ENGINEERED MUTATION SEQADV 7MAR SER C 73 UNP P03367 GLY 573 ENGINEERED MUTATION SEQADV 7MAR ILE C 82 UNP P03367 VAL 582 ENGINEERED MUTATION SEQADV 7MAR VAL C 85 UNP P03367 ILE 585 ENGINEERED MUTATION SEQRES 1 D 99 PRO GLN ILE THR LEU TRP LYS ARG PRO PHE VAL THR ILE SEQRES 2 D 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 D 99 GLY ALA ASP ASP THR VAL LEU GLU GLU MET ASN LEU PRO SEQRES 4 D 99 GLY ARG TRP LYS PRO LYS ILE VAL GLY GLY VAL GLY GLY SEQRES 5 D 99 LEU ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO ILE GLU SEQRES 6 D 99 ILE CYS GLY HIS LYS ALA VAL SER THR VAL LEU VAL GLY SEQRES 7 D 99 PRO THR PRO ILE ASN ILE VAL GLY ARG ASN LEU LEU THR SEQRES 8 D 99 GLN ILE GLY CYS THR LEU ASN PHE SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO PHE VAL THR ILE SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL LEU GLU GLU MET ASN LEU PRO SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS ILE VAL GLY GLY VAL GLY GLY SEQRES 5 A 99 LEU ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO ILE GLU SEQRES 6 A 99 ILE CYS GLY HIS LYS ALA VAL SER THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO ILE ASN ILE VAL GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY CYS THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO PHE VAL THR ILE SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL LEU GLU GLU MET ASN LEU PRO SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS ILE VAL GLY GLY VAL GLY GLY SEQRES 5 B 99 LEU ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO ILE GLU SEQRES 6 B 99 ILE CYS GLY HIS LYS ALA VAL SER THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO ILE ASN ILE VAL GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY CYS THR LEU ASN PHE SEQRES 1 C 99 PRO GLN ILE THR LEU TRP LYS ARG PRO PHE VAL THR ILE SEQRES 2 C 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 C 99 GLY ALA ASP ASP THR VAL LEU GLU GLU MET ASN LEU PRO SEQRES 4 C 99 GLY ARG TRP LYS PRO LYS ILE VAL GLY GLY VAL GLY GLY SEQRES 5 C 99 LEU ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO ILE GLU SEQRES 6 C 99 ILE CYS GLY HIS LYS ALA VAL SER THR VAL LEU VAL GLY SEQRES 7 C 99 PRO THR PRO ILE ASN ILE VAL GLY ARG ASN LEU LEU THR SEQRES 8 C 99 GLN ILE GLY CYS THR LEU ASN PHE HET 017 A 101 75 HET 017 C 101 75 HETNAM 017 (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3- HETNAM 2 017 [[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2- HETNAM 3 017 HYDROXYPROPYLCARBAMATE HETSYN 017 DARUNAVIR; TMC114; UIC-94017 FORMUL 5 017 2(C27 H37 N3 O7 S) FORMUL 7 HOH *359(H2 O) HELIX 1 AA1 GLY D 86 ILE D 93 1 8 HELIX 2 AA2 GLY A 86 THR A 91 1 6 HELIX 3 AA3 GLY B 86 ILE B 93 1 8 HELIX 4 AA4 GLY C 86 ILE C 93 1 8 SHEET 1 AA1 4 GLN D 2 ILE D 3 0 SHEET 2 AA1 4 THR C 96 ASN C 98 -1 O LEU C 97 N ILE D 3 SHEET 3 AA1 4 THR D 96 ASN D 98 -1 N ASN D 98 O THR C 96 SHEET 4 AA1 4 GLN C 2 ILE C 3 -1 O ILE C 3 N LEU D 97 SHEET 1 AA2 8 TRP D 42 GLY D 49 0 SHEET 2 AA2 8 GLY D 52 ILE D 66 -1 O GLN D 58 N LYS D 43 SHEET 3 AA2 8 HIS D 69 VAL D 77 -1 O HIS D 69 N ILE D 66 SHEET 4 AA2 8 VAL D 32 LEU D 33 1 N LEU D 33 O LEU D 76 SHEET 5 AA2 8 ILE D 84 VAL D 85 -1 O ILE D 84 N VAL D 32 SHEET 6 AA2 8 GLN D 18 LEU D 24 1 N LEU D 23 O VAL D 85 SHEET 7 AA2 8 PHE D 10 ILE D 15 -1 N ILE D 13 O LYS D 20 SHEET 8 AA2 8 GLY D 52 ILE D 66 -1 O GLU D 65 N LYS D 14 SHEET 1 AA3 4 GLN A 2 ILE A 3 0 SHEET 2 AA3 4 THR B 96 ASN B 98 -1 O LEU B 97 N ILE A 3 SHEET 3 AA3 4 THR A 96 ASN A 98 -1 N ASN A 98 O THR B 96 SHEET 4 AA3 4 GLN B 2 ILE B 3 -1 O ILE B 3 N LEU A 97 SHEET 1 AA4 8 LYS A 43 GLY A 49 0 SHEET 2 AA4 8 GLY A 52 ILE A 66 -1 O VAL A 56 N LYS A 45 SHEET 3 AA4 8 HIS A 69 VAL A 77 -1 O ALA A 71 N ILE A 64 SHEET 4 AA4 8 VAL A 32 LEU A 33 1 N LEU A 33 O LEU A 76 SHEET 5 AA4 8 ILE A 84 VAL A 85 -1 O ILE A 84 N VAL A 32 SHEET 6 AA4 8 GLN A 18 LEU A 24 1 N LEU A 23 O VAL A 85 SHEET 7 AA4 8 PHE A 10 ILE A 15 -1 N ILE A 13 O LYS A 20 SHEET 8 AA4 8 GLY A 52 ILE A 66 -1 O GLU A 65 N LYS A 14 SHEET 1 AA5 8 LYS B 43 GLY B 49 0 SHEET 2 AA5 8 GLY B 52 ILE B 66 -1 O GLY B 52 N GLY B 49 SHEET 3 AA5 8 HIS B 69 VAL B 77 -1 O VAL B 77 N ARG B 57 SHEET 4 AA5 8 VAL B 32 LEU B 33 1 N LEU B 33 O LEU B 76 SHEET 5 AA5 8 ILE B 84 VAL B 85 -1 O ILE B 84 N VAL B 32 SHEET 6 AA5 8 GLN B 18 LEU B 24 1 N LEU B 23 O VAL B 85 SHEET 7 AA5 8 PHE B 10 ILE B 15 -1 N ILE B 13 O LYS B 20 SHEET 8 AA5 8 GLY B 52 ILE B 66 -1 O GLU B 65 N LYS B 14 SHEET 1 AA6 8 TRP C 42 GLY C 49 0 SHEET 2 AA6 8 GLY C 52 ILE C 66 -1 O GLN C 58 N LYS C 43 SHEET 3 AA6 8 HIS C 69 VAL C 77 -1 O SER C 73 N ILE C 62 SHEET 4 AA6 8 VAL C 32 LEU C 33 1 N LEU C 33 O LEU C 76 SHEET 5 AA6 8 ILE C 84 VAL C 85 -1 O ILE C 84 N VAL C 32 SHEET 6 AA6 8 GLN C 18 LEU C 24 1 N LEU C 23 O VAL C 85 SHEET 7 AA6 8 PHE C 10 ILE C 15 -1 N ILE C 13 O LYS C 20 SHEET 8 AA6 8 GLY C 52 ILE C 66 -1 O GLU C 65 N LYS C 14 SITE 1 AC1 20 ASP A 25 GLY A 27 ASP A 29 ASP A 30 SITE 2 AC1 20 VAL A 47 GLY A 48 VAL A 50 ILE A 82 SITE 3 AC1 20 ILE A 84 HOH A 207 ARG B 8 ASP B 25 SITE 4 AC1 20 GLY B 27 ALA B 28 ASP B 30 VAL B 47 SITE 5 AC1 20 GLY B 48 GLY B 49 HOH B 106 HOH B 140 SITE 1 AC2 21 ASP C 25 GLY C 27 ALA C 28 ASP C 29 SITE 2 AC2 21 ASP C 30 GLY C 48 GLY C 49 VAL C 50 SITE 3 AC2 21 ILE C 84 HOH C 234 ASP D 25 GLY D 27 SITE 4 AC2 21 ALA D 28 ASP D 30 VAL D 32 GLY D 48 SITE 5 AC2 21 GLY D 49 PRO D 81 ILE D 82 HOH D 102 SITE 6 AC2 21 HOH D 114 CRYST1 56.692 36.340 103.523 90.00 99.31 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017639 0.000000 0.002891 0.00000 SCALE2 0.000000 0.027518 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009789 0.00000